Founded in 1983, Caxton Associates is a North American venture capital firm based in New York. The fund typically invests between $10 million and $50 million in startups, with a focus on the Health Care and Pharmaceutical industries. Caxton Associates has a track record of successful exits, particularly in 2018, and its top activity year was in 2010. The fund typically participates in rounds with three other investors and prefers to invest in startups that are 4-5 years old. While Caxton Associates is a significant investor, startups in its portfolio also receive funding from VantagePoint Capital Partners, Sofinnova Investments, and Pappas Ventures. The fund's most frequent investments are in the United States, aligning with its country of origin. Caxton Associates aims to deliver consistent absolute returns for its investors by managing assets through global macro hedge funds and trading them in global markets.